Global Heparin Sodium Industry Report: Overview with Product Scope, Opportunities Risk, Market Driving Force

Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.Europe heparin sodium market is occupied by local suppliers and Chinese manufacturers. Currently, there are many heparin sodium products producing companies in the Europe heparin sodium industry. The main market players are Shenzhen Hepalink, Nanjing King-friend, Dongcheng Biochemicals, Pharma Action, Opocrin and Bioibérica. The Europe sales of heparin sodium will increase to 72006 Kg in 2017 from 66667 Kg in 2012 with average growth rate of 1.56%.

The Europe consumption value of heparin sodium decreases with the 11.04% average growth rate. France and Germany are the main consumption regions. In 2016, these two regions occupied 58.34% of the Europe consumption volume in total.

Heparin sodium production methods include salt solution method and enzyme extraction method. With medical effect of heparin sodium, the downstream application industries will need more heparin sodium products. So, heparin sodium has a huge market potential in the future. Manufacturers are trying to produce good performance heparin sodium through improving technology.

The major raw materials for heparin sodium products are fresh intestine, pancreatic enzymes, ion exchange resin, preservative other auxiliary materials. Fluctuations in the price of the upstream product will impact on the production cost of heparin sodium. The production cost of heparin sodium is also an important factor which could impact the price of heparin sodium.

We tend to believe this industry is a rising industry, and the consumption increasing degree will show a smooth growth curve. According to the economy development status, the price presents decreasing trend from 2012 to 2017. And, there is fluctuation in gross margin.

Access Report Details at:

The worldwide market for Heparin Sodium is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019

This report focuses on the Heparin Sodium in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Purchase this premium research report at:

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Heparin Sodium product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Heparin Sodium, with price, sales, revenue and global market share of Heparin Sodium in 2017 and 2018.

Chapter 3, the Heparin Sodium competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Heparin Sodium breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Heparin Sodium market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Heparin Sodium sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Ask your report related queries at:

Posted by on Wednesday May 22 2019, 6:50 PM EDT. All trademarks acknowledged. Filed under Chemicals, Healthcare. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Latest News

Log in